These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28836148)

  • 1. Anti-diabetic actions of esculentin-2CHa(1-30) and its stable analogues in a diet-induced model of obesity-diabetes.
    Vasu S; Ojo OO; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YHA
    Amino Acids; 2017 Oct; 49(10):1705-1717. PubMed ID: 28836148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Esculentin-2CHa-Related Peptides Modulate Islet Cell Function and Improve Glucose Tolerance in Mice with Diet-Induced Obesity and Insulin Resistance.
    Ojo OO; Srinivasan DK; Owolabi BO; Vasu S; Conlon JM; Flatt PR; Abdel-Wahab YH
    PLoS One; 2015; 10(10):e0141549. PubMed ID: 26512980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esculentin-2CHa(1-30) and its analogues: stability and mechanisms of insulinotropic action.
    Vasu S; McGahon MK; Moffett RC; Curtis TM; Conlon JM; Abdel-Wahab YH; Flatt PR
    J Endocrinol; 2017 Mar; 232(3):423-435. PubMed ID: 28115493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial actions of the [A14K] analog of the frog skin peptide PGLa-AM1 in mice with obesity and degenerative diabetes: A mechanistic study.
    Musale V; Moffett RC; Conlon JM; Flatt PR; Abdel-Wahab YH
    Peptides; 2021 Feb; 136():170472. PubMed ID: 33338546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulinotropic, glucose-lowering, and beta-cell anti-apoptotic actions of peptides related to esculentin-1a(1-21).NH
    Musale V; Abdel-Wahab YHA; Flatt PR; Conlon JM; Mangoni ML
    Amino Acids; 2018 Jun; 50(6):723-734. PubMed ID: 29549522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and characterisation of novel, enzymatically stable oxytocin analogues with beneficial antidiabetic effects in high fat fed mice.
    Mohan S; McCloskey AG; McKillop AM; Flatt PR; Irwin N; Moffett RC
    Biochim Biophys Acta Gen Subj; 2021 Mar; 1865(3):129811. PubMed ID: 33309687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial long-term antidiabetic actions of N- and C-terminally modified analogues of apelin-13 in diet-induced obese diabetic mice.
    Parthsarathy V; Hogg C; Flatt PR; O'Harte FPM
    Diabetes Obes Metab; 2018 Feb; 20(2):319-327. PubMed ID: 28730728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dogfish glucagon analogues counter hyperglycaemia and enhance both insulin secretion and action in diet-induced obese diabetic mice.
    O'Harte FP; Ng MT; Lynch AM; Conlon JM; Flatt PR
    Diabetes Obes Metab; 2016 Oct; 18(10):1013-24. PubMed ID: 27357054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucoregulatory, endocrine and morphological effects of [P5K]hymenochirin-1B in mice with diet-induced glucose intolerance and insulin resistance.
    Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jul; 389(7):769-81. PubMed ID: 27068334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial actions of esculentin-2CHa(GA30) on high sucrose-induced oxidative stress in Drosophila melanogaster.
    Adesanoye OA; Farodoye OM; Adedara AO; Falobi AA; Abolaji AO; Ojo OO
    Food Chem Toxicol; 2021 Nov; 157():112620. PubMed ID: 34656695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptides from frog skin with potential for development into agents for Type 2 diabetes therapy.
    Conlon JM; Mechkarska M; Abdel-Wahab YH; Flatt PR
    Peptides; 2018 Feb; 100():275-281. PubMed ID: 28887047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo insulinotropic properties of the multifunctional frog skin peptide hymenochirin-1B: a structure-activity study.
    Owolabi BO; Ojo OO; Srinivasan DK; Conlon JM; Flatt PR; Abdel-Wahab YH
    Amino Acids; 2016 Feb; 48(2):535-47. PubMed ID: 26439377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves lipid profile of high-fat fed mice.
    O'Harte FPM; Parthsarathy V; Hogg C; Flatt PR
    PLoS One; 2018; 13(8):e0202350. PubMed ID: 30157220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained treatment with a stable long-acting oxyntomodulin analogue improves metabolic control and islet morphology in an experimental model of type 1 diabetes.
    Irwin N; Pathak V; Pathak NM; Gault VA; Flatt PR
    Diabetes Obes Metab; 2015 Sep; 17(9):887-95. PubMed ID: 26095087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brevinin-2-related peptide and its [D4K] analogue stimulate insulin release in vitro and improve glucose tolerance in mice fed a high fat diet.
    Abdel-Wahab YH; Patterson S; Flatt PR; Conlon JM
    Horm Metab Res; 2010 Aug; 42(9):652-6. PubMed ID: 20496306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.
    Tanday N; English A; Lafferty RA; Flatt PR; Irwin N
    Front Endocrinol (Lausanne); 2021; 12():674704. PubMed ID: 34054734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon from the phylogenetically ancient paddlefish provides a template for the design of a long-acting peptide with effective anti-diabetic and anti-obesity activities.
    Graham GV; Conlon JM; Abdel-Wahab YH; Flatt PR
    Eur J Pharmacol; 2020 Jul; 878():173101. PubMed ID: 32320703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln.
    Hasib A; Ng MT; Khan D; Gault VA; Flatt PR; Irwin N
    Eur J Pharmacol; 2018 Sep; 834():126-135. PubMed ID: 30025814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [I10W]tigerinin-1R enhances both insulin sensitivity and pancreatic beta cell function and decreases adiposity and plasma triglycerides in high-fat mice.
    Srinivasan DK; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YH
    Acta Diabetol; 2016 Apr; 53(2):303-15. PubMed ID: 26138324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel CCK-8/GLP-1 Hybrid Peptide Exhibiting Prominent Insulinotropic, Glucose-Lowering, and Satiety Actions With Significant Therapeutic Potential in High-Fat-Fed Mice.
    Irwin N; Pathak V; Flatt PR
    Diabetes; 2015 Aug; 64(8):2996-3009. PubMed ID: 25883113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.